Description
For this week’s assignment, you will submit an annotated bibliography of at least 15 sources pertaining Preventing ACCESS Related Infections in Hemodilaysis patients. This bibliography will be used to as the basis for your literature review section in the next course.
In order to become a content expert in the area you have chosen, you will need to do a thorough Aspen Library or Boolean search that retrieves at least 15 sources related to your topic. Then, you will need to create an annotated bibliography. All references should be in current APA style.
The following specifications are required for this assignment:
- Length: 2250 – 3000 words
- Structure: Include a title page and reference page in APA style. These do not count toward the minimal word amount for this assignment.
- References: Include at least 15 scholarly sources to support your claims. Use the appropriate APA style in-text citations and references for all resources utilized to answer the questions.
Explanation & Answer
Attached.
1
Name
Date
2
Annotated Bibliography
Preventing Access-related Infections in Hemodialysis Patients
Al Himali, N., Abdelrahman, A., Al Suleimani, Y. M., Balkhair, A., & AlZakwani, I. (2023). Access-and non-access-related infections among patients
receiving haemodialysis: Experience of an academic centre in Oman. IJID
regions, 7, 252-255.
This article is written by different expert authors and researchers. They provided
us with information regarding access and non-access-related infections among
the patients who are on hemodialysis. Approximately half of the hemodialysis
patients had a health issue when they started. The most common illness among
those receiving dialysis was pneumonia. A total of twenty per cent of patients
receiving hemodialysis experienced systemic infections. Klebsiella pneumoniae
was shown to be the primary cause of pneumonia. At Sultan Qaboos University
Hospital in Muscat, Oman, 287 sick patients had hemodialysis and they
participated in the research. The research findings showed that multidrugresistant organisms were much more common among the clinical cases under
investigation (31.0%). This figure is cause for concern. This study is related to
our research as it discusses access-related infection among the patients receiving
hemodialysis.
Auguste, B. L., & Chan, C. T. (2022). Infections in Hemodialysis
Patients. Evidence‐Based Nephrology, pp. 2, 48–65.
The authors of this research are well-known in medical research. They have
discussed infections in hemodialysis patients. Infections have risen in prevalence
to become the second most prevalent cause of mortality among hemodialysis
3
(HD) patients, after cardiac disease, which remains the sole primary cause. This
research discusses the risk factors for vascular and nonvascular infections in
individuals with HD in great depth. In addition, current knowledge regarding the
prevention and treatment of a variety of diseases is provided. Frequent
nosocomial infections and bloodborne viral infections are discussed in relation to
HD patients. Additionally, the essay describes how this group has developed
resistance to infectious organisms. The location and type of entry site, the
techniques used for cannulation, and the presence of compromised immune
systems are additional variables that may impact the prognosis of an HD patient.
The ability of apparatus and surfaces that have come into contact with the
Hepatitis B virus to retain viability for a maximum of seven days at ambient
temperature is an essential element that upholds environmental stability. The risk
of infection for patients undergoing hemodialysis continues to be significant.
This research provides us with information regarding different infections among
hemodialysis patients.
Fisher, M., & Mokrzycki, M. H. (2023). Infectious Complications From Vascular
Access. In Handbook of Dialysis Therapy (pp. 198-210). Elsevier.
Well-known researchers conduct this research. They have discussed the most
common reason for hospitalization, sickness, and mortality among hemodialysis
patients is infections brought on by arterial access. It is not ideal that central
venous catheters (CVCs) have a greater prevalence of vascular access illnesses
than arteriovenous fistulas (AVFs) and grafts (AVGs). Even though the "Fistula
First/Catheter Last" campaign has resulted in a notable decline in the use of
central venous catheters (CVCs) in common patients over the last ten years,
CVCs remain the most prevalent way to establish a blood vascular connection at
4
the beginning of hemodialysis. This approach aims to increase patient safety by
lowering the quantity of CVCs used during hemodialysis. The Centers for
Disease Control and Prevention (CDC) key measures for hemodialysis CVC care
have been shown to lower the incidence of sepsis and CVC-associated
bloodstream infections (BSIs). This study looks at the clinical results of
hemodialysis CVCs, AVGs, and AVFs. Strategies for CVC, AVG, and AVF
disease prevention and therapy are also reviewed. This research is helpful for our
topic as it highlights the infection complications from vascular access.
Fisher, M., Golestaneh, L., Allon, M., Abreo, K., & Mokrzycki, M. H. (2020).
Prevention of bloodstream infections in patients undergoing
hemodialysis. Clinical Journal of the American Society of Nephrology:
CJASN, 15(1), 132.
The authors of this research are well-known in the nephrology field. The main
goal of the Making Dialysis Safer for Patients Coalition and, more recently, the
CDC's partnership with the “Nephrologists Transforming Dialysis Safety
Initiative of the American Society of Nephrology” has been to eradicate
bloodstream infections in hemodialysis settings. Patients receiving dialysis using
a central venous catheter bear a higher risk of systemic infections linked to
vascular access. It has been demonstrated that the CDC's main bloodstream
infection prevention initiatives may reduce catheter-associated bloodstream
infections....
